Back to DD
DD: Earnings, Valuation & Sustainability in Focus
$DDNEUTRALChemicals

DD: Earnings, Valuation & Sustainability in Focus

DuPont ($DD) heads into the November earnings window with mixed signals: broad analyst optimism and SBTi validation contrast with divergent EPS/P-E metrics and a mean analyst target below the current price. This report breaks down the fundamentals, valuation discrepancies, and catalysts to help you weigh the scenarios.

October 31, 202612 min read
Current Price
$140.05
-0.38%
Analyst Rating
Strong Buy
Price Target
$135.25
-3.4% upside
P/E Ratio
304.46

Executive Summary

Investment Thesis: DuPont ($DD) presents a mixed picture heading into the November earnings release. The business shows steady revenue, improving cash generation, and a high-profile ESG milestone with SBTi validation, but valuation metrics vary widely across data sources and trailing EPS figures are inconsistent, creating uncertainty around headline P/E multiples and implied upside. Analysts are largely constructive, yet the mean price target sits slightly below current levels, signaling limited consensus upside. Upcoming Q3 results and margin/organic demand signals are the next near-term catalysts that could resolve the ambiguity.

Current Price: $140.05, as of Friday, October 30 | Key Metric: Market Cap $18.91B | Stance: NEUTRAL

Company Overview

DuPont de Nemours, Inc. ($DD) is a diversified chemicals company supplying materials and solutions across agriculture, electronics, transportation, and industrial markets. The firm combines specialty polymers, engineered materials, and advanced solutions that are embedded into customers products and manufacturing processes.

Key Products & Competitive Position

  • Core Business: Specialty materials, performance chemicals, and engineered solutions sold to industrial and high-growth end markets.
  • Key Products: Specialty polymers, electronic materials, separation science products, and industrial chemicals used in automotive, electronics, packaging, and infrastructure applications.
  • Competitive Moat: Broad product portfolio, long-term customer relationships, technical know-how, and scale in specialty chemistries that create switching costs for customers.

Recent Developments

Recent items include SBTi validation of DuPont’s 2035 emissions targets and 2050 net-zero ambition, signaling stronger ESG positioning and potential preference from sustainability-focused customers and investors. Portfolio and cost actions plus improved end-market demand have been cited by research outlets as factors positioning DD to outperform near-term earnings expectations. There are also recent notable institutional filings showing increased stake activity.

Financial Snapshot

Market Cap$18.91B
P/E Ratio304.46 (see note)
52-Week Range$100.02 - $157.98
Dividend Yield1.71%
EPS (TTM)$0.40 (source variance)
ROE0.34%

Revenue & Earnings Trends

Reported total revenue is roughly $7.0B on recent figures, with revenue growth near mid-single digits year over year according to public data. One data source cites EBITDA near $1.58B and operating cash flow north of $1.19B, with free cash flow around $1.84B, suggesting healthy cash generation relative to the revenue base. Earnings growth has shown volatility, with some sources indicating high year-over-year percentage growth, likely influenced by non-recurring items and prior-year comparisons.

Balance Sheet Highlights

The balance sheet appears manageable. Total cash is reported around $1.74B while total debt is approximately $3.18B, yielding modest net leverage for a diversified chemicals company. Liquidity ratios are solid, with a current ratio of 2.43 and quick ratio around 1.64 in some reports, indicating capacity to fund near-term obligations and operational flexibility.

Valuation Analysis

Current Valuation Metrics

Forward P/E~17.5 (source dependent)vs Industry: ~15-20
PEG Ratio~1.72Growth-adjusted
EV/EBITDA~12.9vs Historical: ~10-13
P/S Ratio~2.7vs Peers: mixed

Historical Comparison

Reported multiples vary by source. One dataset flags an unusually high P/E of 304.46 reflecting a TTM EPS of $0.40. Other widely used data points show trailing EPS near $3.72 and a trailing P/E near 37.7, with forward EPS implying a forward P/E in the high teens. The discrepancy likely reflects differences between GAAP and adjusted EPS timing, or significant one-time items in the trailing period. On a forward basis, multiples are closer to chemicals peers, while trailing GAAP metrics look distorted.

Fair Value Estimate

Reconciling the inputs, a reasonable fair value assessment blends the mean of analyst targets and forward multiple comparisons. The reported analyst mean is $135.25 which implies a slight downside to current price. Using a conservative forward P/E of 17 applied to forward EPS estimates implies a value in the mid-$130s to low-$150s depending on the earnings series used. Given earnings and cash flow strength versus mixed trailing metrics, a fair value range of roughly $130 to $155 captures the midpoint of market expectations and forward valuation. This range is presented for analytical context, not as investment guidance.

Competitive Landscape

Market Position

Market Share: Diversified across multiple specialty segments | Ranking: Top-5 in multiple specialty chemicals niches

Key Competitors

Air Products & Chemicals (APD)Large industrial gases and performance materials provider with global scale
$AVNTSpecialty materials provider with focus on performance polymers
$HUNHoneywell and other diversified materials firms competing in advanced materials

Competitive Advantages

  • Moat 1: Technical depth and R&D capabilities that support differentiated specialty products.
  • Moat 2: Long-term supply relationships with OEMs in electronics and automotive markets.
  • Moat 3: Scale and geographic footprint that help optimize manufacturing and logistics.

Earnings Track Record

Last 4 Quarters: 3 beats / 1 miss

Recent Earnings History

Q3 2026 (reported 08/04/26)EPS $1.88 vs $1.76 estBEAT
Q2 2026Adjusted results showed improvement vs prior yearBEAT
Q1 2026Some measures below street due to timing and one-offsMISS
Q4 2025Solid cash flow and margin discipline notedBEAT

Guidance Trend

Management has emphasized cost productivity and margin expansion while calling out gradual end-market recovery in target verticals. Guidance has been incrementally updated in past quarters with an eye on cash conversion and capital allocation toward higher-return initiatives. Analysts will be watching the November 3 earnings release for any guidance revisions and margin details.

Analyst Sentiment

Consensus Rating: Strong Buy

Strong Buy: 3 Buy: 11 Hold: 4 Sell: 0

Price Targets

  • Low: $53
  • Mean: $135.25 (-3.4% downside vs current price $140.05)
  • High: $172

Recent Analyst Actions

Market research outlets and analysts have pointed to cost cuts, productivity initiatives, and recovering end-market demand as drivers that could support beats in the quarter. The consensus stance remains constructive, but the mean price target slightly under the current price flags uneven conviction across the analyst base.

Recent News & Catalysts

Key Developments

  • Q3 Earnings Preview (Zacks, 10/29/2026): Zacks highlighted DD among chemical names likely to beat given recovering end demand and self-help measures.
  • SBTi Validation (PRNewsWire, 10/29/2026): Science Based Targets initiative validated DuPont’s 2035 emissions-reduction goals and 2050 net-zero commitment, strengthening ESG credentials.
  • Portfolio & Investor Activity (10/26/2026): Public filings show some funds increasing exposure, and media coverage noted DD as a beaten-down growth stock that some investors view as value-like.

Upcoming Catalysts

Next Earnings: 2026-11-03 | Key Events: Q3 results, management commentary on organic demand, margin trajectory, and any guidance updates

Technical Outlook

Current Price: $140.05 vs 52-Week High: $157.98 (-11.3% from high), as of Friday, October 30.

Trend Analysis

Price action shows recovery from a 52-week low near $100.02 to a current level above $140. Momentum indicators have been mixed with recent consolidation. Volume has been near average, and the recent split and dividend actions have changed per-share metrics for some investors. The stock is trading in the upper half of its 52-week range but below the all-time high.

Key Levels

  • Resistance: $158, $172
  • Support: $130, $115

Bull vs Bear Case

Bull Case

  • Catalyst 1: Q3 beat and upgraded guidance, confirming end-market recovery and prompting multiple expansion.
  • Catalyst 2: SBTi validation strengthens ESG profile, attracting sustainability-focused capital and supporting client wins.
  • Catalyst 3: Improved free cash flow and successful productivity programs fund higher-return investments or buybacks, supporting earnings growth.

Bull Target: $172 (+22.7%)

Bear Case

  • Risk 1: Continued EPS volatility and one-time items keep reported GAAP metrics distorted, sustaining valuation skepticism.
  • Risk 2: Slower-than-expected demand in key end markets such as automotive and electronics compresses margins.
  • Risk 3: Large dispersion in analyst targets signals asymmetric downside if execution or guidance misses surface.

Bear Target: $53 (-62.2%)

Risks to Consider

  • Valuation Risk: Discrepant EPS and P/E figures across sources make headline valuation unclear, increasing model risk for investors relying on trailing GAAP numbers.
  • Competitive Risk: Competition from larger integrated chemical firms and niche specialists could pressure pricing and margins in commoditized product lines.
  • Macro Risk: End-market cyclicality in industries like automotive, electronics, and construction can materially affect demand and profit cycles.
  • Execution Risk: Delivery of productivity and cost-savings programs must outpace any revenue softness to protect margin trajectory.

Bottom Line

Investment Verdict: NEUTRAL

DuPont sits at an informational crossroads. Cash flow and ESG progress are tangible positives, while conflicting EPS and multiple metrics create ambiguity around valuation. Analysts skew positive, yet the mean target implies limited upside versus current price. Q3 results on November 3 are pivotal for clarity on demand, margins, and guidance.

Action Items for Investors

  • Long-term investors: Review the firm's cash generation and strategic plans for higher-return investments and monitor whether sustainability commitments translate into measurable commercial wins. Consider the company within a portfolio context rather than focusing solely on short-term price moves.
  • Short-term traders: Watch the November 3 earnings release and follow guidance reaction closely. Volatility around the print could provide trading opportunities, but confirm liquidity and set clear stop limits.
  • Risk management: Given the valuation data variance, use position sizing and stop-loss rules. Validate which EPS series you use for valuation models and stress-test scenarios for weaker demand or margin compression.

What to Watch This Week

  • Q3 earnings release, expected 2026-11-03, plus management commentary on guidance and margins.
  • Analyst updates and any revisions to price targets following the quarter.
  • Market reaction to SBTi validation and any customer or contract announcements tied to sustainability initiatives.

Share this report

Share this article

Spread the word on social media

Think DD will outperform? Prove it.

Free practice contests — earn Alpha Coins
Enter a Contest

Disclaimer: StockAlpha.ai content is for informational and educational purposes only. It is not personalized investment advice. Sentiment ratings and market analysis reflect data-driven observations, not buy, sell, or hold recommendations. Always consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results.

Spotted something wrong? Report an error.